[ad_1]
Careful contact research was also conducted for all those who come into contact with patients, she said.
Dr. Ling said: "Patients with resistant organisms such as Candida auris are immediately isolated in the isolation room and, when they are discharged, the rooms are subjected to final cleaning and disinfection. the environment is carried out with a treatment with ultraviolet oxide vapor or hydrogen peroxide. "
She added that there had been "no outbreaks or spread" of C. auris in the community here.
Last July, Dr. Tan Yen Ee and Associate Professor Tan Ai Ling of the SGH Microbiology Department reported the cases in a letter to the local medical journal Annals.
C. auris is resistant to major antifungal drugs and is particularly deadly for patients with compromised immune systems, the New York Times reported.
It is spread by direct contact and not by aerial transmission.
According to the US Centers for Disease Control and Prevention, it kills about half of patients who contract it within 90 days.
The first case in Singapore was detected in a 52-year-old Singapore-born woman with multiple fractures of a limb following a road accident in India in 2012.
She was treated in an Indian hospital and transferred to SGH for further treatment.
The fungus and other organisms were detected in his fractured bone of the right thigh or femur. She received several medications, including antibiotics and an antifungal drug called fluconazole.
The fungus subsequently became resistant to fluconazole, but no other antifungal was administered to the patient as she recovered well and then left the hospital.
The second case involved a 24-year-old Bangladeshi who came to Singapore for medical treatment in 2016. He had been admitted to three Bangladeshi hospitals for metastatic carcinoma, a type of cancer. He received GHS chemotherapy and later discovered that he was carrying C. auris fluconazole-resistant in his blood.
Another antifungal called anidulafungin, effective against fungi, has been prescribed. However, the man then returned to Bangladesh against the advice of a doctor after only 10 days of treatment here.
The last case involved a 69-year-old American who had contracted an infection that exacerbated his chronic obstructive pulmonary disease (pulmonary disease) during a tour of Bangladesh in late 2016.
The man was admitted to the intensive care unit of a hospital in Bangladesh where he was treated with the help of antibiotics. He was transferred to SGH in early 2017. He had other complications, including cardiac arrest. C. auris was then found in his blood.
After discussions with the patient's family, no antifungal therapy was administered. He received palliative care and eventually died.
https://www.straitstimes.com/singapore/health/at-least-three-cases-of-candida-auris-infection-detected-in-singapore-since-2012
[ad_2]
Source link
